Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-12-19 to 2024-12-30
Current total value of award: $91.5
Description: 8511089131!MIDAZOLAM HYDROCHLO